Clinical Trials Browser

OTHER × Neoplasms, Plasma Cell × ibrutinib × Clear all

NCT03702725 2026-01-06

Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma

Phase 1 Completed

14 enrolled 15 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02943473 2020-12-16

Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients

Phase 2 Terminated

9 enrolled 6 charts

Smoldering Multiple Myeloma, Neoplasms, Plasma Cell